Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT04489537 |
| Consolidated Lead Sponsor | Catalyst Biosciences |
| Therapeutic Condition Cohort | Rare Genetic, Women's Health, and Other |
| Clinical Trial Phase | Phase III |
| Overall Recruitment Status | TERMINATED |
| Registered Enrollment | 18 participants (ACTUAL) |
| Registered Start Date | 2021-05-04 |
| WhyStopped Classification | Safety / Toxicity / Adverse Events |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Phoenix Children's Hospital | Phoenix, AZ | Open Hospital Dossier -> |
| Azienda Ospedaliero Universitaria Careggi | Florence, Italy | Open Hospital Dossier -> |
| Azienda Ospedaliera Universitaria Federico II | Naples, Italy | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Rare Genetic, Women's Health, and Other Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.